Citadel Advisors’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Citadel Advisors’s Portfolio SSAAW Stock Details SSAAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,666	Closed	-$2K	–	15886
2022 Q3	$2K	Sell	33,666 -275	-0.8%	-$20	﹤0.01%	12439
2022 Q2	$3K	Sell	33,941 -166,991	-83%	-$28K	﹤0.01%	12718
2022 Q1	$45K	Sell	200,932 -23,975	-11%	-$9.94K	﹤0.01%	12874
2021 Q4	$121K	Sell	224,907 -162,225	-42%	-$113K	﹤0.01%	12521
2021 Q3	$271K	Buy	387,132 +186,300	+93%	+$148K	﹤0.01%	11285
2021 Q2	$172K	Sell	200,832 -200	-0.1%	-$151	﹤0.01%	12350
2021 Q1	$121K	Buy	+201,032	New	+$125K	﹤0.01%	12287

Citadel Advisors's SSAAW Position: Q4 2022 in Review

Citadel Advisors sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 33,666 shares — an estimated $2K sold.

Citadel Advisors first reported a position in SSAAW in Q1 2021 and held it in 7 quarters. The position peaked at $271K in Q3 2021. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

Citadel Advisors reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 33,666 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022, an estimated $2K.
Citadel Advisors first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q1 2021 and held it in 7 quarters.
Citadel Advisors's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $271K in Q3 2021.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.